FGADX
Price
$50.30
Change
-$0.71 (-1.39%)
Updated
Jun 22 closing price
Net Assets
3.12B
RYZCX
Price
$187.43
Change
-$3.52 (-1.84%)
Updated
Jun 22 closing price
Net Assets
150.03M
Interact to see
Advertisement

FGADX vs RYZCX

FGADX vs RYZCX Comparison Chart in %
View a ticker or compare two or three
VS
FGADX vs. RYZCX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGADX is a Buy and RYZCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FGADX has more cash in the bank: 3.13B vs. RYZCX (150M). FGADX pays higher dividends than RYZCX: FGADX (9.06) vs RYZCX (3.96). FGADX was incepted earlier than RYZCX: FGADX (29 years) vs RYZCX (25 years). RYZCX (2.33) is less costly to investors than FGADX (0.62). RYZCX is a more actively managed with annual turnover of: 452.00 vs. FGADX (22.76). FGADX has a lower initial minimum investment than RYZCX: FGADX (0) vs RYZCX (2500). FGADX annual gain was more profitable for investors over the last year : 79.15 vs. RYZCX (66.13). FGADX return over 5 years is better than : 174.45 vs. RYZCX (94.45).
FGADXRYZCXFGADX / RYZCX
Total Expense Ratio0.622.2827%
Annual Report Gross Expense Ratio0.622.3327%
Fund Existence29 years25 years-
Gain YTD-0.352-0.199177%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.13B150M2,083%
Annual Yield % from dividends9.063.96229%
Returns for 1 year79.1566.13120%
Returns for 3 years261.53172.21152%
Returns for 5 years174.4594.45185%
Returns for 10 years284.80140.96202%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI23.750.37
+1.58%
Greenwich LifeSciences
STBA47.310.47
+1.00%
S&T Bancorp
MGLD1.060.01
+0.95%
Marygold Companies (The)
HALO68.980.43
+0.63%
Halozyme Therapeutics
WENNU10.41N/A
N/A
Wen Acqusition Corp